Pay in 4 interest-free payments of $40.50 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
1 μM and IL4 driven proliferation with IC50=0
Valrubicin in combination with radiation enhances the cytotoxicity
Smiles: CN1CCN(CC1)C1=CC(NC2=NC3C4=C(CCC=3C=N2)C(=NN4CCO)C(N)=O)=C(C=C1)OC(F)(F)F
Double-blind study of pardoprunox
The spontaneous blinking properties of HM Janelia Fluor® 526
NV-5138 C AR Degrader-4 TFA 1 μM and IL4 drivenNV 5138 is an orally and centrally active small molecule drug for the treatment of major depressive disorder (MDD). It directly and selectively activates the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway by binding to and modulating sestrin2, a leucine amino acid sensor and upstream regulatory pathway. The mTORC1 pathway is the same signaling pathway that the NMDA receptor antagonist ketamine activates in the medial prefrontal
US$ 454.00
US$ 454.00
US$ 544.50
US$ 454.00
US$ 384.00